Suraksha Diagnostic, specializing in pathology and radiology testing services, derives most of its revenue from West Bengal. While the company faced a financial setback in FY23, it has recently shown signs of recovery, according to Swastika Investment.
Suraksha Diagnostic's Rs 846 crore IPO opens for subscription. Check GMP, other details - The Economic TimesSuraksha Diagnostic IPO Day 1: GMP, Price Band, Subscription, Key Dates, and Review - The Economic TimesSuraksha Diagnostic IPO opens today: Is it worth investing? Analysts weigh - Business StandardSuraksha Diagnostic IPO opens today: Should you subscribe or avoid the issue? - Business Today
